These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28680751)

  • 1. Tocilizumab in patients with multisystem Erdheim-Chester disease.
    Berti A; Cavalli G; Guglielmi B; Biavasco R; Campochiaro C; Tomelleri A; Nicoletti R; Panzacchi A; Ferrarini M; Dagna L
    Oncoimmunology; 2017; 6(6):e1318237. PubMed ID: 28680751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
    Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim-Chester disease.
    Cao XX; Niu N; Sun J; Cai H; Wang FD; Wang YN; Duan MH; Zhou DB; Li J
    Orphanet J Rare Dis; 2019 Jan; 14(1):11. PubMed ID: 30630516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erdheim-Chester disease with multisystem involvement evaluated by multimodal imaging: A case report.
    Liu J; Gao L; Pu H; He W; Peng L
    Radiol Case Rep; 2022 Mar; 17(3):784-789. PubMed ID: 35024076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Radiologic Responses to Cladribine for the Treatment of Erdheim-Chester Disease.
    Goyal G; Shah MV; Call TG; Litzow MR; Hogan WJ; Go RS
    JAMA Oncol; 2017 Sep; 3(9):1253-1256. PubMed ID: 28253394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erdheim-Chester disease (ECD), an inflammatory myeloid neoplasia].
    Haroche J; Papo M; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
    Presse Med; 2017 Jan; 46(1):96-106. PubMed ID: 27234902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erdheim-Chester Disease: Case Report with Aggressive Multisystem Manifestations and Review of the Literature.
    Alotaibi S; Alhafi O; Nasr H; Eltayeb K; Elyamany G
    Case Rep Oncol; 2017; 10(2):501-507. PubMed ID: 28690524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
    Haroche J; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
    Expert Rev Clin Immunol; 2015; 11(9):1033-42. PubMed ID: 26197238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease.
    Haroche J; Cohen-Aubart F; Emile JF; Maksud P; Drier A; Tolédano D; Barete S; Charlotte F; Cluzel P; Donadieu J; Benameur N; Grenier PA; Besnard S; Ory JP; Lifermann F; Idbaih A; Granel B; Graffin B; Hervier B; Arnaud L; Amoura Z
    J Clin Oncol; 2015 Feb; 33(5):411-8. PubMed ID: 25422482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report.
    Kim S; Lee M; Shin HJ; Lee J; Suh YL
    Childs Nerv Syst; 2016 May; 32(5):893-6. PubMed ID: 26466952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erdheim-Chester Disease: The Importance of Information Integration.
    Nikonova A; Esfahani K; Chausse G; Probst S; Petrogiannis-Haliotis T; Knecht H; Gyger G
    Case Rep Oncol; 2017; 10(2):613-619. PubMed ID: 28868020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Patient With Erdheim-Chester Disease Presenting With Intestinal Obstruction as the Initial Symptom: A Case Report.
    Zhou X; Zhai D; Yang J; Shi D; Lu K; Cai W; Fan G; Ju S
    Front Oncol; 2022; 12():849578. PubMed ID: 35372026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive Aortic Thromboembolism in a Patient With Erdheim-Chester Disease: A Case Report.
    He J; Fang X; Zhang X; Chen K; Huang J
    Front Cardiovasc Med; 2022; 9():882817. PubMed ID: 35647053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients.
    Arnaud L; Gorochov G; Charlotte F; Lvovschi V; Parizot C; Larsen M; Ghillani-Dalbin P; Hervier B; Kahn JE; Deback C; Musset L; Amoura Z; Haroche J
    Blood; 2011 Mar; 117(10):2783-90. PubMed ID: 21205927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease.
    Ferrero E; Corti A; Haroche J; Belloni D; Colombo B; Berti A; Cavalli G; Campochiaro C; Villa A; Cohen-Aubart F; Amoura Z; Doglioni C; Dagna L; Ferrarini M
    Oncoimmunology; 2016 Jul; 5(7):e1181244. PubMed ID: 27622037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erdheim-Chester disease (ECD): Case report, clinical and basic investigations, and review of literature.
    Adawi M; Bisharat B; Bowirrat A
    Medicine (Baltimore); 2016 Oct; 95(42):e5167. PubMed ID: 27759649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality imaging of spleen involvement in Erdheim-Chester disease mimicking splenic hemangioma: a unique case report.
    Huang W; Qiu Y; Chen Z; Yang Q; Nong L; Kang L
    Am J Nucl Med Mol Imaging; 2023; 13(3):118-125. PubMed ID: 37457326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim-Chester disease patients following BRAF inhibitor monotherapy.
    Mazor RD; Weissman R; Luckman J; Domachevsky L; Diamond EL; Abdel-Wahab O; Shapira S; Hershkovitz-Rokah O; Groshar D; Shpilberg O
    Neurooncol Adv; 2020; 2(1):vdaa024. PubMed ID: 32642685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Diagnostic Challenge: Erdheim Chester Disorder.
    Razi M; Qubtia M; Hassan A; Hussain M; Hameed A
    Mol Imaging Radionucl Ther; 2019 Mar; 28(1):30-33. PubMed ID: 30942060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.